EP1049471A1 - Zusammensetzungen und behandlung von atopischer dermatitis, angiooedem und anderen erkrankungen durch antihistamine und glucokortikosteroide - Google Patents

Zusammensetzungen und behandlung von atopischer dermatitis, angiooedem und anderen erkrankungen durch antihistamine und glucokortikosteroide

Info

Publication number
EP1049471A1
EP1049471A1 EP99912236A EP99912236A EP1049471A1 EP 1049471 A1 EP1049471 A1 EP 1049471A1 EP 99912236 A EP99912236 A EP 99912236A EP 99912236 A EP99912236 A EP 99912236A EP 1049471 A1 EP1049471 A1 EP 1049471A1
Authority
EP
European Patent Office
Prior art keywords
composition
allergic
substituted
antihistamine
glucocorticoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99912236A
Other languages
English (en)
French (fr)
Inventor
Sergio Ulloa Lugo
Jose Villacampa Ramos
Sergio Morales Arellano
Olivier Michel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of EP1049471A1 publication Critical patent/EP1049471A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99912236A 1999-03-01 1999-03-01 Zusammensetzungen und behandlung von atopischer dermatitis, angiooedem und anderen erkrankungen durch antihistamine und glucokortikosteroide Withdrawn EP1049471A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/004502 WO2000051605A1 (en) 1999-03-01 1999-03-01 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids

Publications (1)

Publication Number Publication Date
EP1049471A1 true EP1049471A1 (de) 2000-11-08

Family

ID=22272279

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99912236A Withdrawn EP1049471A1 (de) 1999-03-01 1999-03-01 Zusammensetzungen und behandlung von atopischer dermatitis, angiooedem und anderen erkrankungen durch antihistamine und glucokortikosteroide

Country Status (4)

Country Link
EP (1) EP1049471A1 (de)
JP (1) JP2001510485A (de)
AU (1) AU3065299A (de)
WO (1) WO2000051605A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026658A2 (en) * 1999-10-08 2001-04-19 Schering Corporation Topical nasal treatment using desloratadine
JP2006517217A (ja) * 2003-02-10 2006-07-20 ノバルティス アクチエンゲゼルシャフト コルチコイドおよび／またはカルシニューリン阻害剤耐性疾患を処置するための、コルチコイドおよび免疫抑制剤を含んでなる医薬組合せ剤
DE10330243A1 (de) 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
US20050192261A1 (en) * 2003-09-15 2005-09-01 Jost-Price Edward R. Methods and reagents for the treatment of immunoinflammatory disorders
NZ588373A (en) * 2004-05-19 2012-01-12 Emisphere Tech Inc Topical cromolyn formulations
US20070003557A1 (en) * 2005-04-21 2007-01-04 Andres Forero Method for treating cancer using premedication
DE112008001135A5 (de) * 2007-06-08 2010-04-15 Bayer Consumer Care Ag Antiinflammatorische Wirkstoffkombinationen zur Behandlung von Erkrankungen der Haut und Schleimhäute
US20090136430A1 (en) * 2007-11-27 2009-05-28 Dugger Harry A Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis
EP2443134A2 (de) * 2009-06-16 2012-04-25 Schering Corporation Neue [3,2-c]heteroarylsteroide als glucocorticoidrezeptoragonisten, zusammensetzungen und verwendung
BR102012030828A2 (pt) 2012-12-03 2014-09-16 Ems Sa Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso
MX2022015335A (es) 2020-12-04 2023-01-11 Laboratorios Silanes S A De C V Combinacion farmaceutica de un corticosteroide y un antihistaminico para el tratamiento y control del componente inflamatorio de procesos alergicos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT704206E (pt) * 1994-09-30 2003-01-31 Mika Pharma G Fur Die E Und V Composicao farmaceutica
EP0780127A1 (de) * 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0051605A1 *

Also Published As

Publication number Publication date
WO2000051605A1 (en) 2000-09-08
AU3065299A (en) 2000-09-21
JP2001510485A (ja) 2001-07-31

Similar Documents

Publication Publication Date Title
JP4893305B2 (ja) 局所又は他の局部投与用のソフト抗炎症性ステロイドの活性及び／又は作用持続性の増強
US4945089A (en) Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
US20030191096A1 (en) Method of hormonal therapy
WO2000051605A1 (en) Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
JPH0334934A (ja) 眼病治療におけるスタチン誘導体の使用
JP2005526843A (ja) 電気痙攣療法（「ｅｃｔ」）に対する治療応答を増大させるための方法
US6423721B1 (en) Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US7776846B2 (en) Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
JP5278313B2 (ja) 輸送体増強コルチコステロイド活性
JP2011506607A (ja) 免疫炎症性障害の処置のための治療法
AU2016294185B2 (en) Estrogen receptor β partial agonist having estrogen receptor α inhibitory effect, and therapeutic agent for gynecological disorders using same
US7786101B2 (en) Cardiovascular protection using anti-aldosteronic progestins
US5358943A (en) Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids
MXPA99002272A (en) Compositions and methods for the treatment of atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoi
US20020028793A1 (en) Use of estrogens and delta-gonadien-21-3,20-diones
WO2000015226A1 (en) Antihistamines for treating non-infective sinusitis or otitis media
CN101987103A (zh) 一种碳酸酐酶抑制剂的眼用组合物
CN101987104A (zh) 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物
JP2002543136A (ja) 併用療法における抗プロゲスタゲンの使用
EP0966289A1 (de) Budesonid zur behandlung von cholestatischen lebererkrankungen
JPH03275624A (ja) 新規な皮膚潰瘍治療剤

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990428

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: LT PAYMENT 19990428;LV PAYMENT 19990428;RO PAYMENT 19990428

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MICHEL, OLIVIER

Inventor name: ARELLANO, SERGIO MORALES

Inventor name: RAMOS, JOSE VILLACAMPA

Inventor name: LUGO, SERGIO ULLOA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021001

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1028736

Country of ref document: HK